Journal of Okayama Medical Association
Published by Okayama Medical Association

<Availability>
Full-text articles are available 3 years after publication.

Biological response modifier (BRM) による肝転移抑制と肝局所免疫に関する研究

高橋 正彦 岡山大学医学部第一外科教室
Thumnail 108_129.pdf 462 KB
抄録
Efficacy of a combination therapy with two biological response modifiers (BRMs), oral PSK and systemic IL-2, was evaluated in a mouse model system of hepatic metastasis from colon cancer. Hepatic metastasis was significantly suppressed and the duration of survival was significantly prolonged by combination therapy, but not by either therapy alone. The therapeutic effects were attributable to the mechanism that non-MHC restricted cytotoxicity of hepatic non-parenchymal lymphocytes activated by IL-2 was augmented by PSK-activated Kupffer cells with direct cell-to-cell contact. These results suggest that local immunity in the liver plays an important role in the formation and development of hepatic metastasis and that the combination of these two BRMs may provide an effective new clinical therapy.
キーワード
肝移転
肝リンパ球
クッパー細胞
PSK
interleukin 2 (IL-2)
備考
原著
ISSN
0030-1558
NCID
AN00032489